FDA granted accelerated approval to Hepcludex (bulevirtide) for Hepatitis Delta on May 22, 2026 — the first-ever U.S. treatment for HDV. What patients need to know.
Hepatitis Delta Is the Deadliest Form of Viral Hepatitis — and the U.S. Just Got Its First Treatment for It
by | Jun 16, 2026 | Uncategorized | 0 comments
Recent Comments